Proportion of the Malignancy Diagnosis Between Cytological Techniques Versus the Combination of Both Cell block and Cytological Techniques in Pleural Effusion
Main Article Content
Abstract
Background: Pleural effusion is common in routine medical practice and can be due to many different underlying diseases. Thoracentesis is a diagnostic procedure for patients with pleural effusion. It is the most important investigation because of non-invasive and helps in faster reporting, especially when malignancy is suspected. The cytologic evaluation is performed on different specimen preparation techniques which include conventional smear, cytospin, and cell block preparations. Many studies support that the combination of conventional smear and cell block techniques can significantly increase the diagnostic yield for malignant pleural effusion as well as subtypes of malignancy.
Objective: To evaluate the proportion of the malignancy diagnosis between cytological techniques versus the combination of both cell block and cytological techniques in pleural effusion.
Methods: The study was a retrospective observational case-control study by collecting data on Thai patients who lived in Surin province with clinically suspected of malignant pleural effusion and underwent thoracentesis with pleural cytological evaluation in Surin Hospital from January 1st 2022 to December 31st 2022. Patient demographics and specimen characteristics were reviewed and evaluated by descriptive statistics. The proportions of malignancy diagnosis between cytological techniques versus the combination of both cell block and cytological techniques in pleural effusion were analyzed by inferential statistics using McNemar's Test. A p-value of <0.05 was considered statistically significant.
Results: The 601 cytological reports of pleural effusion were reviewed however 109 reports from 86 patients were submitted for evaluation. All patients with an average age of 64 years old showed pleural effusion with clinically suspected of malignancy. The cytological study was performed by two different techniques which were cytological techniques (CT) and the combination of both CT and Cell block preparation (CB). The concordant diagnoses of both techniques were identified in all the malignancies conversely, the borderline category was changed. The proportions of malignant had increased from 56.0% to 63.3% and the borderline had eased from 18.4% to 2.8% which showed statistically significant in all 3 categories at benign (P=0.002), borderline (P=0.000), and malignant (P=0.008). Moreover, the malignancy subtypes were identified, especially metastatic carcinoma (P=0.002) and metastatic adenocarcinoma (P=0.000)
Conclusion: The proportions of malignant pleural effusion showed a statistically significant increase by the combinations of CT and CB techniques compared to the use of the CT alone as well as the malignancy subtypes especially metastatic carcinoma and metastatic adenocarcinoma.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran pathologic basis of disease 9th ed. Philadelphia ; Elsevier health sciences ; 2014 : 721-2.
Dermawan JKT, Policarpio-Nicolas ML. Malignancies in Pleural, Peritoneal, and Pericardial Effusions. Arch Pathol Lab Med 2020;144(9):1086-91. doi: 10.5858/arpa.2019-0429-OA.
Assawasaksakul T, Boonsarngsuk V, Incharoen P. A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion. J Thorac Dis 2017;9(9):3161-7. doi: 10.21037/jtd.2017.08.52.
Gayen S. Malignant Pleural Effusion: Presentation, Diagnosis, and Management. Am J Med 2022;135(10):1188-92. doi: 10.1016/j.amjmed.2022.04.017.
Chandra A, Crothers B, Kurtycz D, Schmitt F, editors. The international system for serous fluid cytopathology. n.p. : Springer ; 2020 : 239-53.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 2013;137(5):668-84. doi: 10.5858/arpa.2012-0263-RA.
Rekhtman N, Brandt SM, Sigel CS, Friedlander MA, Riely GJ, Travis WD, et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing. J Thorac Oncol 2011;6(3):451-8. doi: 10.1097/JTO.0b013e31820517a3.
สุพัตรา รักเอียด, ศุกล ภักดีนิติ, วิษณุ ปานจันทร์, อาคม ชัยวีระวัฒนะ, วีรวุฒิ อิ่มสำราญ, บรรณาธิการ. แนวทางการตรวจรักษาและวินิจฉัยโรคมะเร็งปอด (ปรับปรุงครั้งที่ 2). กรุงเทพฯ: โฆสิตการพิมพ์ ; 2558.
แพทยสภา. พระราชบัญญัติที่เกี่ยวข้องกับการแพทย์. [อินเตอร์เน็ท]. [สืบค้นเมื่อ 14 กรกฎาคม 2566]. ค้นได้จาก:URL: https://www.tmc.or.th/statute.php.
ประภาพร พรสุริยะศักดิ์. น้ำในช่องเยื่อหุ้มปอด (pleural effusion). [อินเตอร์เน็ท]. 2023 [สืบค้นเมื่อ 14 กรกฎาคม 2566]. ค้นได้จาก:URL:https://www.rama.mahidol.ac.th/med/sites/default/files/public/pdf/medicinebook1/Pleural effusion อ ประภาพร.pdf.
Amin A, DeLellis RA, Fava JL. Modifying phrases in surgical pathology reports: introduction of Standardized Scheme of Reporting Certainty in Pathology Reports (SSRC-Path). Virchows Arch 2021;479(5):1021-9. doi: 10.1007/s00428-021-03155-w.
Ugurluoglu C, Kurtipek E, Unlu Y, Esme H, Duzgun N. Importance of the cell block technique in diagnosing patients with non-small cell carcinoma accompanied by pleural effusion. Asian Pac J Cancer Prev 2015;16(7):3057-60. doi: 10.7314/apjcp.2015.16.7.3057.
Ma ES, Ng WK, Wong CL. EGFR gene mutation study in cytology specimens. Acta Cytol 2012;56(6):661-8. doi: 10.1159/000343606.
กรกช สร้อยทอง. ความสัมพันธ์ระหว่างการกลายพันธุ์ของยีน Epidermal growth factor receptor (EGFR) กับข้อมูลพื้นฐานของผู้ป่วยและลักษณะสิ่งส่งตรวจ ของผู้ป่วยมะเร็งปอดชนิด non-small cell lung carcinoma (NSCLC). วารสารการแพทย์โรงพยาบาลศรีสะเกษ สุรินทร์ บุรีรัมย์ 2566;38(1):259-68.
Grigoriadou GΙ, Esagian SM, Ryu HS, Nikas IP. Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management. J Pers Med 2020;10(4):206. doi: 10.3390/jpm10040206.